{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T15:51:26Z","timestamp":1794498686540,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41409-025-02600-7","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T13:19:16Z","timestamp":1744982356000},"page":"971-977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Results of the Latin American Bone Marrow Transplantation Society (LABMT) activity survey 2019-2022: the impact of the COVID-19 pandemic and the increase in related haploidentical donors"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8048-2892","authenticated-orcid":false,"given":"Sebastian","family":"Galeano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0343-2610","authenticated-orcid":false,"given":"Carmem","family":"Bonfim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-102X","authenticated-orcid":false,"given":"Amado","family":"Karduss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2555-6673","authenticated-orcid":false,"given":"Gregorio","family":"Jaimovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6904-9345","authenticated-orcid":false,"given":"Andr\u00e9s","family":"G\u00f3mez-De Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Bettarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Simione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinthya","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6554-483X","authenticated-orcid":false,"given":"Helen","family":"Baldomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-5189","authenticated-orcid":false,"given":"Daniel","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-5543","authenticated-orcid":false,"given":"Ana Lisa","family":"Basquiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0552-444X","authenticated-orcid":false,"given":"Mariano","family":"Berro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Remaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Amaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Seber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Barriga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3942-6987","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Puga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calixto","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0460-6427","authenticated-orcid":false,"given":"David","family":"G\u00f3mez-Almaguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Gayt\u00e1n Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-0653","authenticated-orcid":false,"given":"Guillermo J.","family":"Ruiz-Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninotzka","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Liz","family":"Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-4320","authenticated-orcid":false,"given":"Alfredo","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Pag\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3347-7230","authenticated-orcid":false,"given":"Marcos","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4737-1103","authenticated-orcid":false,"given":"Dietger","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Rondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-3137","authenticated-orcid":false,"given":"Crist\u00f3bal","family":"Frutos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"2600_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, S\u00e1nchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. European Society for Blood and Marrow Transplantation (EBMT). Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant. 2022;57:1217\u201339.","journal-title":"Bone Marrow Transplant"},{"key":"2600_CR2","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.bbmt.2020.03.002","volume":"26","author":"AS Kanate","year":"2020","unstructured":"Kanate AS, Majhail NS, Savani BN, Bredeson C, Champlin RE, Crawford S, et al. Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2020;26:1247\u201356.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2600_CR3","unstructured":"Latin American Bone Marrow Transplantation Society - LABMT. https:\/\/www.wbmt.org\/member-societies-of-wbmt\/labmt\/ Accessed 05 May 2024."},{"key":"2600_CR4","unstructured":"Worldwide Network for Blood & Marrow Transplantation - WBMT. https:\/\/www.wbmt.org Accessed 05 May 2024."},{"key":"2600_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/bmt.2016.361","volume":"52","author":"G Jaimovich","year":"2017","unstructured":"Jaimovich G, Martinez Rolon J, Baldomero H, Rivas M, Hanesman I, Bouzas L, et al. Latin America: the next region for haematopoietic transplant progress. Bone Marrow Transplant. 2017;52:671\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"2600_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41409-022-01630-9","volume":"57","author":"C Correa","year":"2022","unstructured":"Correa C, Gonzalez-Ramella O, Baldomero H, Basquiera AL, Baena R, Arcuri L, et al. Latin American Bone Marrow Transplantation Group (LABMT); Worldwide Network for Blood and Marrow Transplantation (WBMT). Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012. Bone Marrow Transplant. 2022;57:881\u20138.","journal-title":"Bone Marrow Transplant."},{"key":"2600_CR7","unstructured":"List of Disease Classifications - EBMT: https:\/\/www.ebmt.org\/sites\/default\/files\/2023-09\/EBMT%20List%20of%20disease%20classifications%20v1.0.pdf Accessed 05 May 2024."},{"key":"2600_CR8","unstructured":"United Nations - World Population Prospects 2022. https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/ Accessed 05 May 2024."},{"key":"2600_CR9","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303:1617\u201324.","journal-title":"JAMA"},{"key":"2600_CR10","unstructured":"World Bank Open Data, World Bank Group: https:\/\/data.worldbank.org\/indicator Accessed 21 December 2024."},{"key":"2600_CR11","unstructured":"The Global Health Observatory, World Health Organization: https:\/\/www.who.int\/data\/gho\/data\/indicators. Accessed 05 March 2025."},{"key":"2600_CR12","unstructured":"Statistical Databases and Publications \u2013 CEPALSTAT, Economic Commission for Latin America and the Caribbean (ECLAC): https:\/\/statistics.cepal.org\/portal\/cepalstat\/index.html Accessed 05 March 2025."},{"key":"2600_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","volume":"107","author":"D Niederwieser","year":"2022","unstructured":"Niederwieser D, Baldomero H, Bazuaye N, Bupp C, Chaudhri N, Corbacioglu S, et al. One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica. 2022;107:1045\u201353.","journal-title":"Haematologica."},{"key":"2600_CR14","doi-asserted-by":"publisher","unstructured":"Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, et al. Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors. Haematologica. 2024 May 9. https:\/\/doi.org\/10.3324\/haematol.2024.285002.","DOI":"10.3324\/haematol.2024.285002"},{"key":"2600_CR15","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.bbmt.2020.08.018","volume":"26","author":"AJ Cowan","year":"2020","unstructured":"Cowan AJ, Baldomero H, Atsuta Y, Mikhael J, Aljurf M, Seber A, et al. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study. Biol Blood Marrow Transplant. 2020;26:2372\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2600_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1402888","volume":"371","author":"A Palumbo","year":"2014","unstructured":"Palumbo A, Cavallo F, Gay F, Di Raimondo F, Ben Yehuda D, Petrucci MT, et al. Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med. 2014;371:895\u2013905.","journal-title":"N Engl J Med"},{"key":"2600_CR17","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/S1470-2045(15)00389-7","volume":"16","author":"F Gay","year":"2015","unstructured":"Gay F, Oliva S, Petrucci MT, Conticello C, Catalano L, Corradini P, et al. Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial. Lancet Oncol. 2015;16:1617\u201329.","journal-title":"Lancet Oncol"},{"key":"2600_CR18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1611750","volume":"376","author":"M Attal","year":"2017","unstructured":"Attal M, Lauwers-Cances V, Hulin C, Leleu X, Caillot D, Escoffre M, et al. IFM 2009 Study. Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma. N Engl J Med. 2017;376:1311\u201320.","journal-title":"N Engl J Med"},{"key":"2600_CR19","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.1016\/S2352-3026(20)30099-5","volume":"7","author":"M Cavo","year":"2020","unstructured":"Cavo M, Gay F, Beksac M, Pantani L, Petrucci MT, Dimopoulos MA, et al. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02\/HO95): a multicentre, randomised, open-label, phase 3 study. Lancet Haematol. 2020;7:e456\u2013e468.","journal-title":"Lancet Haematol"},{"key":"2600_CR20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S1470-2045(21)00535-0","volume":"22","author":"F Gay","year":"2021","unstructured":"Gay F, Musto P, Rota-Scalabrini D, Bertamini L, Belotti A, Galli M, et al. Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial. Lancet Oncol. 2021;22:1705\u201320.","journal-title":"Lancet Oncol"},{"key":"2600_CR21","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1016\/S2352-3026(22)00350-7","volume":"10","author":"K Yong","year":"2023","unstructured":"Yong K, Wilson W, de Tute RM, Camilleri M, Ramasamy K, Streetly M, et al. Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial. Lancet Haematol. 2023;10:e93\u2013e106.","journal-title":"Lancet Haematol"},{"key":"2600_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/bjh.16124","volume":"188","author":"VT de Moraes Hungria","year":"2020","unstructured":"de Moraes Hungria VT, Mart\u00ednez-Ba\u00f1os DM, Pe\u00f1afiel CR, Miguel CE, Vela-Ojeda J, Remaggi G, Duarte FB, et al. Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato-Oncology (HOLA) Observational Study, 2008-2016. Br J Haematol. 2020;188:383\u201393.","journal-title":"Br J Haematol"},{"key":"2600_CR23","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.clml.2018.08.005","volume":"19","author":"RJ Pessoa de Magalh\u00e3es Filho","year":"2019","unstructured":"Pessoa de Magalh\u00e3es Filho RJ, Crusoe E, Riva E, Bujan W, Conte G, Navarro Cabrera JR, et al. Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries. Clin Lymphoma Myeloma Leuk. 2019;19:e43\u2013e50.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"2600_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa2116133","volume":"386","author":"FL Locke","year":"2022","unstructured":"Locke FL, Miklos DB, Jacobson CA, Perales MA, Kersten MJ, Oluwole OO, et al. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma. N Engl J Med. 2022;386:640\u201354.","journal-title":"N Engl J Med"},{"key":"2600_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa2116596","volume":"386","author":"MR Bishop","year":"2022","unstructured":"Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, et al. Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma. N Engl J Med. 2022;386:629\u201339.","journal-title":"N Engl J Med"},{"key":"2600_CR26","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood.2022018730","volume":"141","author":"JS Abramson","year":"2023","unstructured":"Abramson JS, Solomon SR, Arnason J, Johnston PB, Glass B, Bachanova V, et al. Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study. Blood. 2023;141:1675\u201384.","journal-title":"Blood."},{"key":"2600_CR27","doi-asserted-by":"crossref","unstructured":"Passweg JR, Baldomero H, Ciceri F, de la C\u00e1mara R, Glass B, Greco R, et al. Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transplant. 2024;59:803\u201312.","DOI":"10.1038\/s41409-024-02248-9"},{"key":"2600_CR28","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","volume":"26","author":"A D\u2019Souza","year":"2020","unstructured":"D\u2019Souza A, Fretham C, Lee SJ, Arora M, Brunner J, Chhabra S, et al. Current Use of and Trends in Hematopoietic Cell Transplantation in the United States. Biol Blood Marrow Transplant. 2020;26:e177\u2013e182.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2600_CR29","doi-asserted-by":"publisher","first-page":"647425","DOI":"10.3389\/fneur.2021.647425","volume":"12","author":"I Murrieta-\u00c1lvarez","year":"2021","unstructured":"Murrieta-\u00c1lvarez I, Cantero-Fortiz Y, Le\u00f3n-Pe\u00f1a AA, Olivares-Gazca JC, Priesca-Mar\u00edn JM, Ruiz-Delgado GJ, et al. The 1000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-M\u00e9xico Program: A Myriad of Experiences and Knowledge. Front Neurol. 2021;12:647425.","journal-title":"Front Neurol"},{"key":"2600_CR30","doi-asserted-by":"publisher","first-page":"279.e1","DOI":"10.1016\/j.jtct.2022.12.013","volume":"29","author":"MC Tokaz","year":"2023","unstructured":"Tokaz MC, Baldomero H, Cowan AJ, Saber W, Greinix H, Koh MBC, et al. An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia. Transplant Cell Ther. 2023;29:279.e1\u2013279.e10.","journal-title":"Transplant Cell Ther."},{"key":"2600_CR31","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/bmt.2016.35","volume":"51","author":"RP Gale","year":"2016","unstructured":"Gale RP, Seber A, Bonfim C, Pasquini M. Haematopoietic cell transplants in Latin America. Bone Marrow Transplant. 2016;51:898\u2013905.","journal-title":"Bone Marrow Transplant"},{"key":"2600_CR32","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1038\/s41409-021-01321-x","volume":"56","author":"G Jaimovich","year":"2021","unstructured":"Jaimovich G, Gale RP, Hanesman I, Vazquez A, Hammerschlak N, Simoes BP, et al. The paradox of haematopoietic cell transplant in Latin America. Bone Marrow Transplant. 2021;56:2382\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2600_CR33","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jtct.2023.02.024","volume":"29","author":"S Okamoto","year":"2023","unstructured":"Okamoto S, Iida M, Hamad N, Duarte FB, Sureda A, Srivastava A, et al. American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting. Transplant Cell Ther. 2023;29:410\u20137.","journal-title":"Transplant Cell Ther."},{"key":"2600_CR34","doi-asserted-by":"crossref","unstructured":"Rizvi SS, Rondelli D. An Analysis and Comparison of the Cost of Blood and Marrow Transplantation (BMT) As a Factor of Gross National Income (GNI) in Low-Middle Income Countries and High-Income Countries: Key Takeaways Regarding Global Access to BMT. Transplantation and Cellular Therapy, Volume 31, Issue 2, Supplement, 2025, Page S325.","DOI":"10.1016\/j.jtct.2025.01.499"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02600-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T03:06:00Z","timestamp":1751857560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02600-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["2600"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02600-7","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andr\u00e9s G\u00f3mez-De Le\u00f3n: Honoraria: Janssen, Sanofi, Abbvie, Astellas, Amgen, BMS, Novartis. Advisory board: Pfizer, Janssen.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}